Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Active, not recruiting · NCT06311851 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, metastatic malignant neoplasm, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT06311851 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pardis Noor Medical Imaging and Cancer Center | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pardis Noor Medical Imaging and Cancer Center | Tehran | Iran | 1 |